Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
NCT03266653· Phase 2· New York Medical College· Source
Contact: Neena Kapoor, MD
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error